RELAY THERAPEUTICS INC (RLAY) Institutional Shareholders
RELAY THERAPEUTICS INC (RLAY) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $4.52B in RLAY holdings during the latest filing period.
Sb Investment Advisers (Uk) Ltd is currently the largest disclosed institutional shareholder of RLAY tracked by InsiderSet, reporting ownership valued at approximately $522.10M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $525.73M, representing an estimated gain of +0.69% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 58% of the total disclosed RLAY value among the investors covered in this analysis. Major shareholders include Sb Investment Advisers (Uk) Ltd, Fmr Llc, Casdin Capital, Llc, and several other long-term asset managers with concentrated positions in RELAY THERAPEUTICS INC (RLAY).
This page ranks the largest institutional RLAY shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
251
Total Reported Value
$4.52B
Largest Holder
Sb Investment Advisers (Uk) Ltd
Largest Position
$522.10M
Insider Transactions (90d)
21
Latest Filing Quarter
Q2 2026
New Institutional Positions
72
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Sb Investment Advisers (Uk) Ltd | 6.81% | 27,904,963 | $522,101,858 | $525,729,503 | +$3,627,645 | +0.69% | |
| Fmr Llc | 0.02% | 20,110,113 | $376,260,219 | $378,874,529 | +$2,614,310 | +0.69% | |
| Casdin Capital, Llc | 15.02% | 16,035,240 | $300,019,340 | $302,103,922 | +$2,084,582 | +0.69% | |
| Blackrock, Inc. | 0.00% | 15,288,202 | $286,042,260 | $288,029,726 | +$1,987,466 | +0.69% | |
| Perceptive Advisors Llc | 4.10% | 14,106,187 | $263,926,759 | $265,760,563 | +$1,833,804 | +0.69% | |
| Commodore Capital Lp | 13.37% | 12,000,000 | $224,520,000 | $226,080,000 | +$1,560,000 | +0.69% | |
| State Street Corp | 0.01% | 10,125,381 | $189,474,192 | $190,762,178 | +$1,287,986 | +0.68% | |
| Vanguard Capital Management Llc | 0.00% | 8,964,423 | $167,724,354 | $168,889,729 | +$1,165,375 | +0.69% | |
| Price T Rowe Associates Inc | 0.01% | 7,708,507 | $144,227,000 | $145,228,272 | +$1,001,272 | +0.69% | |
| Nextech Invest, Ltd. | 6.02% | 6,776,506 | $126,788,427 | $127,669,373 | +$880,946 | +0.69% | |
| Bellevue Group Ag | 2.44% | 6,185,970 | $115,739,499 | $116,543,675 | +$804,176 | +0.69% | |
| Geode Capital Management, Llc | 0.00% | 4,726,576 | $88,448,664 | $89,048,692 | +$600,028 | +0.68% | |
| Tcg Crossover Management, Llc | 1.92% | 4,273,356 | $79,954,491 | $80,510,027 | +$555,536 | +0.69% | |
| Morgan Stanley | 0.00% | 3,851,071 | $72,053,540 | $72,554,178 | +$500,638 | +0.69% | |
| Siren, L.L.C. | 1.39% | 3,650,000 | $68,291,500 | $68,766,000 | +$474,500 | +0.69% | |
| Goldman Sachs Group Inc | 0.01% | 3,408,701 | $63,776,796 | $64,219,927 | +$443,131 | +0.69% | |
| Westfield Capital Management Co Lp | 0.20% | 3,343,496 | $62,556,810 | $62,991,465 | +$434,655 | +0.69% | |
| Kynam Capital Management, Lp | 3.41% | 3,300,000 | $61,743,000 | $62,172,000 | +$429,000 | +0.69% | |
| Dimensional Fund Advisors Lp | 0.01% | 3,127,564 | $58,533,626 | $58,923,306 | +$389,680 | +0.67% | |
| Spruce Street Capital Lp | 10.95% | 2,984,125 | $55,832,979 | $56,220,915 | +$387,936 | +0.69% | |
| Vanguard Portfolio Management Llc | 0.00% | 2,892,785 | $54,124,007 | $54,500,069 | +$376,062 | +0.69% | |
| Baker Bros. Advisors Lp | 0.27% | 2,826,783 | $52,889,110 | $53,256,592 | +$367,482 | +0.69% | |
| Bank Of America Corp | 0.00% | 2,695,108 | $50,425,471 | $50,775,835 | +$350,364 | +0.69% | |
| Mpm Bioimpact Llc | 2.76% | 2,415,672 | $45,197,223 | $45,511,260 | +$314,037 | +0.69% | |
| Arrowstreet Capital, Limited Partnership | 0.02% | 2,238,929 | $41,890,362 | $42,181,422 | +$291,060 | +0.69% | |
| Alliancebernstein L.P. | 0.01% | 4,095,600 | $40,751,220 | $77,161,104 | +$36,409,884 | +89.35% | |
| Pictet Asset Management Holding Sa | 0.04% | 2,077,297 | $39,220,161 | $39,136,275 | -$83,886 | -0.21% | |
| Northern Trust Corp | 0.00% | 1,953,456 | $36,549,162 | $36,803,111 | +$253,949 | +0.69% | |
| T. Rowe Price Investment Management, Inc. | 0.02% | 1,915,459 | $35,839,000 | $36,087,248 | +$248,248 | +0.69% | |
| Polar Capital Holdings Plc | 0.09% | 1,789,056 | $33,473,238 | $33,705,815 | +$232,577 | +0.69% | |
| Adage Capital Partners Gp, L.L.C. | 0.05% | 1,740,000 | $32,555,400 | $32,781,600 | +$226,200 | +0.69% | |
| Charles Schwab Investment Management Inc | 0.00% | 1,500,817 | $28,080,286 | $28,275,392 | +$195,106 | +0.69% | |
| Elmind Capital, Lp | 6.89% | 1,465,279 | $27,415,370 | $27,605,856 | +$190,486 | +0.69% | |
| Alphabet Inc. | 0.03% | 1,410,029 | $26,381,643 | $26,564,946 | +$183,303 | +0.69% | |
| Panagora Asset Management Inc | 0.07% | 1,291,182 | $24,158,015 | $24,325,869 | +$167,854 | +0.69% | |
| Aqr Capital Management Llc | 0.01% | 1,279,473 | $23,938,940 | $24,105,271 | +$166,331 | +0.69% | |
| Foresite Capital Management Iv, Llc | 8.06% | 1,250,000 | $23,387,500 | $23,550,000 | +$162,500 | +0.69% | |
| Vanguard Fiduciary Trust Co | 0.01% | 1,224,006 | $22,901,152 | $23,060,273 | +$159,121 | +0.69% | |
| Ubs Group Ag | 0.00% | 1,094,980 | $20,487,076 | $20,629,423 | +$142,347 | +0.69% | |
| First Trust Advisors Lp | 0.01% | 1,075,126 | $20,115,607 | $20,255,374 | +$139,767 | +0.69% | |
| Affinity Asset Advisors, Llc | 0.96% | 1,050,000 | $19,645,500 | $19,782,000 | +$136,500 | +0.69% | |
| Frazier Life Sciences Management, L.P. | 0.41% | 1,015,693 | $19,003,616 | $19,135,656 | +$132,040 | +0.69% | |
| Squadron Capital Management Llc | 6.21% | 970,000 | $18,148,700 | $18,274,800 | +$126,100 | +0.69% | |
| Connor, Clark & Lunn Investment Management Ltd. | 0.03% | 961,702 | $17,993,445 | $18,118,466 | +$125,021 | +0.69% | |
| Woodline Partners Lp | 0.05% | 929,692 | $17,394,537 | $17,515,397 | +$120,860 | +0.69% | |
| Jpmorgan Chase & Co | 0.00% | 801,657 | $15,965,989 | $15,103,218 | -$862,771 | -5.40% | |
| Jupiter Asset Management Ltd | 0.07% | 719,576 | $13,463,267 | $13,556,812 | +$93,545 | +0.69% | |
| Two Sigma Investments, Lp | 0.01% | 700,921 | $13,114,232 | $13,205,352 | +$91,120 | +0.69% | |
| Ecor1 Capital, Llc | 0.65% | 697,948 | $13,058,607 | $13,149,340 | +$90,733 | +0.69% | |
| Invesco Ltd. | 0.00% | 692,584 | $12,958,246 | $13,048,283 | +$90,037 | +0.69% |
Frequently asked questions about RLAY
Who owns the most RLAY stock?
The largest holders of RLAY are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for RELAY THERAPEUTICS INC (RLAY).
Is RLAY widely held by superinvestors?
Many widely followed stocks like RLAY appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly RLAY is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.